BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 34042991)

  • 21. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly.
    Shirvani SM; Jiang J; Chang JY; Welsh J; Likhacheva A; Buchholz TA; Swisher SG; Smith BD
    JAMA Surg; 2014 Dec; 149(12):1244-53. PubMed ID: 25321323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing recurrence following anatomic lung resection for clinical stage I non-small cell lung cancer.
    Schuchert MJ; Normolle DP; Awais O; Pennathur A; Wilson DO; Luketich JD; Landreneau RJ
    Lung Cancer; 2019 Feb; 128():145-151. PubMed ID: 30642447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer.
    Tang A; Raja S; Bribriesco AC; Raymond DP; Sudarshan M; Murthy SC; Ahmad U
    Ann Thorac Surg; 2020 Aug; 110(2):424-433. PubMed ID: 32240644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
    Kates M; Swanson S; Wisnivesky JP
    Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A national study of nodal upstaging after thoracoscopic versus open lobectomy for clinical stage I lung cancer.
    Licht PB; Jørgensen OD; Ladegaard L; Jakobsen E
    Ann Thorac Surg; 2013 Sep; 96(3):943-9; discussion 949-50. PubMed ID: 23684159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer.
    Wolf AS; Swanson SJ; Yip R; Liu B; Tarras ES; Yankelevitz DF; Henschke CI; Taioli E; Flores RM;
    Ann Thorac Surg; 2017 Oct; 104(4):1171-1178. PubMed ID: 28669499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncologic Outcomes of Segmentectomy Versus Lobectomy for Clinical T1a N0 M0 Non-Small Cell Lung Cancer.
    Kodama K; Higashiyama M; Okami J; Tokunaga T; Imamura F; Nakayama T; Inoue A; Kuriyama K
    Ann Thorac Surg; 2016 Feb; 101(2):504-11. PubMed ID: 26542438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.
    Hou B; Deng XF; Zhou D; Liu QX; Dai JG
    Ther Adv Respir Dis; 2016 Oct; 10(5):435-43. PubMed ID: 27585599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robotic lobectomy for non-small cell lung cancer (NSCLC): long-term oncologic results.
    Park BJ; Melfi F; Mussi A; Maisonneuve P; Spaggiari L; Da Silva RK; Veronesi G
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):383-9. PubMed ID: 22104677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for a Minimum Number of Lymph Nodes Removed with Non-Small Cell Lung Cancer Resection: Correlating the Number of Nodes Removed with Survival in 98,970 Patients.
    Samayoa AX; Pezzi TA; Pezzi CM; Greer Gay E; Asai M; Kulkarni N; Carp N; Chun SG; Putnam JB
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1005-1011. PubMed ID: 27531307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Racial Disparities in the Surgical Treatment of Clinical Stage I Non-Small Cell Lung Cancer Among Veterans.
    Heiden BT; Eaton DB; Chang SH; Yan Y; Baumann AA; Schoen MW; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
    Chest; 2022 Oct; 162(4):920-929. PubMed ID: 35405111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublobar resection for node-negative lung cancer 2-5 cm in size.
    Stiles BM; Mao J; Harrison S; Lee B; Port JL; Altorki NK; Sedrakyan A
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):858-866. PubMed ID: 31168591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
    Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
    J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease.
    Tsutani Y; Mimura T; Kai Y; Ito M; Misumi K; Miyata Y; Okada M
    J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1089-1096.e1. PubMed ID: 28483268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
    Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Vein-First vs Artery-First Surgical Technique on Circulating Tumor Cells and Survival in Patients With Non-Small Cell Lung Cancer: A Randomized Clinical Trial and Registry-Based Propensity Score Matching Analysis.
    Wei S; Guo C; He J; Tan Q; Mei J; Yang Z; Liu C; Pu Q; Ma L; Yuan Y; Lin F; Zhu Y; Liao H; Wang W; Liu Z; Li Q; Jiang B; Li C; Xia L; Zhao K; Gan F; Cheng J; Wu Z; Wang Y; Lin Y; Kou Y; Che G; Chen L; Li J; Liu L
    JAMA Surg; 2019 Jul; 154(7):e190972. PubMed ID: 31042283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.